AU Stock MarketDetailed Quotes

IBXOA Imagion Biosystems Ltd

Watchlist

0.001
0.0000.00%

20min DelayMarket Closed Apr 12 10:00 AET

0Market Cap0.00P/E (Static)

Imagion Biosystems Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 30, 2022

(FY)Dec 30, 2021

(FY)Dec 30, 2020

(FY)Dec 30, 2019

(FY)Dec 30, 2018

(FY)Dec 30, 2017

Operating cash flow (direct method)

Cash income from operating activities

4.62%3M

13.90%2.86M

-4.05%2.51M

1,596.76%2.62M

23.41%154.46K

125.16K

Revenue from customers

87.87%473.34K

-21.05%251.95K

-42.90%319.13K

261.81%558.84K

23.41%154.46K

--125.16K

Other cash income from operating activities

-3.41%2.52M

18.98%2.61M

6.48%2.2M

--2.06M

----

Cash paid

-37.90%-10.93M

-11.64%-7.93M

-4.21%-7.1M

-0.44%-6.82M

3.30%-6.79M

-7.02M

Payments to suppliers for goods and services

-37.90%-10.93M

-11.64%-7.93M

-4.21%-7.1M

-0.44%-6.82M

3.30%-6.79M

---7.02M

Direct interest paid

-902.23%-166.18K

54.39%-16.58K

-938.45%-36.36K

-31.17%-3.5K

98.04%-2.67K

---136.09K

Direct interest received

129.46%29.83K

1,048.32%13K

-93.16%1.13K

-75.32%16.56K

30.98%67.08K

--51.21K

Operating cash flow

-59.30%-8.07M

-9.63%-5.07M

-10.55%-4.62M

36.32%-4.18M

5.88%-6.57M

---6.98M

Investing cash flow

Cash flow from continuing investing activities

-51.16%-468.73K

-3,845.20%-310.09K

36.37%-7.86K

85.22%-12.35K

77.39%-83.57K

-369.61K

Net PPE purchase and sale

-131.83%-507.32K

-2,684.13%-218.83K

36.37%-7.86K

85.22%-12.35K

77.39%-83.57K

---369.61K

Net other investing changes

142.28%38.59K

---91.26K

----

Cash from discontinued investing activities

Investing cash flow

-51.16%-468.73K

-3,845.20%-310.09K

36.37%-7.86K

85.22%-12.35K

77.39%-83.57K

---369.61K

Financing cash flow

Cash flow from continuing financing activities

-118.70%-962.06K

-64.56%5.15M

336.62%14.52M

-18.95%3.33M

-71.07%4.1M

14.19M

Net issuance payments of debt

----

175.82%233.82K

--84.77K

----

---2.81M

Net common stock issuance

-99.95%2.76K

-62.72%5.51M

339.37%14.77M

-20.57%3.36M

-75.25%4.23M

--17.1M

Net other financing activities

-168.56%-964.82K

25.25%-359.25K

-299.97%-480.62K

6.48%-120.17K

-29.41%-128.49K

---99.29K

Cash from discontinued financing activities

Financing cash flow

-118.70%-962.06K

-64.56%5.15M

336.62%14.52M

-18.95%3.33M

-71.07%4.1M

--14.19M

Net cash flow

Beginning cash position

1.46%13.39M

288.06%13.2M

-22.11%3.4M

-36.46%4.37M

24,764.62%6.87M

--27.64K

Current changes in cash

-3,987.36%-9.51M

-102.35%-232.55K

1,238.48%9.89M

65.90%-868.68K

-137.25%-2.55M

--6.84M

Effect of exchange rate changes

30.90%557.34K

568.11%425.77K

5.94%-90.95K

-331.11%-96.7K

519.50%41.84K

--6.75K

End cash Position

-66.80%4.45M

1.46%13.39M

288.06%13.2M

-22.11%3.4M

-36.46%4.37M

--6.87M

Free cash from

-62.30%-8.58M

-14.17%-5.29M

-10.41%-4.63M

36.93%-4.19M

9.48%-6.65M

---7.35M

Accounting Standards

US-GAAP

	(FY)Dec 30, 2022	(FY)Dec 30, 2021	(FY)Dec 30, 2020	(FY)Dec 30, 2019	(FY)Dec 30, 2018	(FY)Dec 30, 2017
Operating cash flow (direct method)
Cash income from operating activities	4.62%3M	13.90%2.86M	-4.05%2.51M	1,596.76%2.62M	23.41%154.46K	125.16K
Revenue from customers	87.87%473.34K	-21.05%251.95K	-42.90%319.13K	261.81%558.84K	23.41%154.46K	--125.16K
Other cash income from operating activities	-3.41%2.52M	18.98%2.61M	6.48%2.2M	--2.06M	----	----
Cash paid	-37.90%-10.93M	-11.64%-7.93M	-4.21%-7.1M	-0.44%-6.82M	3.30%-6.79M	-7.02M
Payments to suppliers for goods and services	-37.90%-10.93M	-11.64%-7.93M	-4.21%-7.1M	-0.44%-6.82M	3.30%-6.79M	---7.02M
Direct interest paid	-902.23%-166.18K	54.39%-16.58K	-938.45%-36.36K	-31.17%-3.5K	98.04%-2.67K	---136.09K
Direct interest received	129.46%29.83K	1,048.32%13K	-93.16%1.13K	-75.32%16.56K	30.98%67.08K	--51.21K
Operating cash flow	-59.30%-8.07M	-9.63%-5.07M	-10.55%-4.62M	36.32%-4.18M	5.88%-6.57M	---6.98M
Investing cash flow
Cash flow from continuing investing activities	-51.16%-468.73K	-3,845.20%-310.09K	36.37%-7.86K	85.22%-12.35K	77.39%-83.57K	-369.61K
Net PPE purchase and sale	-131.83%-507.32K	-2,684.13%-218.83K	36.37%-7.86K	85.22%-12.35K	77.39%-83.57K	---369.61K
Net other investing changes	142.28%38.59K	---91.26K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-51.16%-468.73K	-3,845.20%-310.09K	36.37%-7.86K	85.22%-12.35K	77.39%-83.57K	---369.61K
Financing cash flow
Cash flow from continuing financing activities	-118.70%-962.06K	-64.56%5.15M	336.62%14.52M	-18.95%3.33M	-71.07%4.1M	14.19M
Net issuance payments of debt	----	----	175.82%233.82K	--84.77K	----	---2.81M
Net common stock issuance	-99.95%2.76K	-62.72%5.51M	339.37%14.77M	-20.57%3.36M	-75.25%4.23M	--17.1M
Net other financing activities	-168.56%-964.82K	25.25%-359.25K	-299.97%-480.62K	6.48%-120.17K	-29.41%-128.49K	---99.29K
Cash from discontinued financing activities
Financing cash flow	-118.70%-962.06K	-64.56%5.15M	336.62%14.52M	-18.95%3.33M	-71.07%4.1M	--14.19M
Net cash flow
Beginning cash position	1.46%13.39M	288.06%13.2M	-22.11%3.4M	-36.46%4.37M	24,764.62%6.87M	--27.64K
Current changes in cash	-3,987.36%-9.51M	-102.35%-232.55K	1,238.48%9.89M	65.90%-868.68K	-137.25%-2.55M	--6.84M
Effect of exchange rate changes	30.90%557.34K	568.11%425.77K	5.94%-90.95K	-331.11%-96.7K	519.50%41.84K	--6.75K
End cash Position	-66.80%4.45M	1.46%13.39M	288.06%13.2M	-22.11%3.4M	-36.46%4.37M	--6.87M
Free cash from	-62.30%-8.58M	-14.17%-5.29M	-10.41%-4.63M	36.93%-4.19M	9.48%-6.65M	---7.35M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall